 | • レポートコード：MRC2312MG05301 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、66ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の心臓病学放射性医薬品市場規模と予測を収録しています。・世界の心臓病学放射性医薬品市場：売上、2018年-2023年、2024年-2029年 ・世界の心臓病学放射性医薬品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の心臓病学放射性医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「テクネチウム-99」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 心臓病学放射性医薬品のグローバル主要企業は、GE Healthcare、 Cardinal Health、 Curium Pharma、 Lantheus Medical Imaging, Inc.、 Eczacıbaşı Monrol Nuclear Products、 Novartis International AG、 Siemens、 China Isotope & Radiation、 Yantai Dongcheng Pharmaceutical、 Jubilant Life Sciences、 Braccoなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、心臓病学放射性医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の心臓病学放射性医薬品市場：タイプ別、2018年-2023年、2024年-2029年 世界の心臓病学放射性医薬品市場：タイプ別市場シェア、2022年 ・テクネチウム-99、フッ素-18、ガリウム-67、その他 世界の心臓病学放射性医薬品市場：用途別、2018年-2023年、2024年-2029年 世界の心臓病学放射性医薬品市場：用途別市場シェア、2022年 ・治療、診断 世界の心臓病学放射性医薬品市場：地域・国別、2018年-2023年、2024年-2029年 世界の心臓病学放射性医薬品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における心臓病学放射性医薬品のグローバル売上、2018年-2023年 ・主要企業における心臓病学放射性医薬品のグローバル売上シェア、2022年 ・主要企業における心臓病学放射性医薬品のグローバル販売量、2018年-2023年 ・主要企業における心臓病学放射性医薬品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 GE Healthcare、 Cardinal Health、 Curium Pharma、 Lantheus Medical Imaging, Inc.、 Eczacıbaşı Monrol Nuclear Products、 Novartis International AG、 Siemens、 China Isotope & Radiation、 Yantai Dongcheng Pharmaceutical、 Jubilant Life Sciences、 Bracco ************************************************************* ・調査・分析レポートの概要 心臓病学放射性医薬品市場の定義 市場セグメント 世界の心臓病学放射性医薬品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の心臓病学放射性医薬品市場規模 世界の心臓病学放射性医薬品市場規模：2022年 VS 2029年 世界の心臓病学放射性医薬品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの心臓病学放射性医薬品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の心臓病学放射性医薬品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：テクネチウム-99、フッ素-18、ガリウム-67、その他 心臓病学放射性医薬品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：治療、診断 心臓病学放射性医薬品の用途別グローバル売上・予測 ・地域別市場分析 地域別心臓病学放射性医薬品市場規模 2022年と2029年 地域別心臓病学放射性医薬品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） GE Healthcare、 Cardinal Health、 Curium Pharma、 Lantheus Medical Imaging, Inc.、 Eczacıbaşı Monrol Nuclear Products、 Novartis International AG、 Siemens、 China Isotope & Radiation、 Yantai Dongcheng Pharmaceutical、 Jubilant Life Sciences、 Bracco ... |
This research report provides a comprehensive analysis of the Cardiology Radiopharmaceuticals market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cardiology Radiopharmaceuticals market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cardiology Radiopharmaceuticals, challenges faced by the industry, and potential opportunities for market players.
The global Cardiology Radiopharmaceuticals market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cardiology Radiopharmaceuticals market presents opportunities for various stakeholders, including Therapeutic Use, Diagnostic Use. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cardiology Radiopharmaceuticals market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cardiology Radiopharmaceuticals market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Cardiology Radiopharmaceuticals market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cardiology Radiopharmaceuticals market.
Market Overview: The report provides a comprehensive overview of the Cardiology Radiopharmaceuticals market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Technetium-99, Fluorine-18), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cardiology Radiopharmaceuticals market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cardiology Radiopharmaceuticals market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cardiology Radiopharmaceuticals market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cardiology Radiopharmaceuticals market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cardiology Radiopharmaceuticals market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cardiology Radiopharmaceuticals market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cardiology Radiopharmaceuticals, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cardiology Radiopharmaceuticals market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cardiology Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Technetium-99
Fluorine-18
Gallium-67
Others
Market segment by Application
Therapeutic Use
Diagnostic Use
Global Cardiology Radiopharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
GE Healthcare
Cardinal Health
Curium Pharma
Lantheus Medical Imaging, Inc.
Eczacıbaşı Monrol Nuclear Products
Novartis International AG
Siemens
China Isotope & Radiation
Yantai Dongcheng Pharmaceutical
Jubilant Life Sciences
Bracco
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiology Radiopharmaceuticals, market overview.
Chapter 2: Global Cardiology Radiopharmaceuticals market size in revenue.
Chapter 3: Detailed analysis of Cardiology Radiopharmaceuticals company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiology Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Cardiology Radiopharmaceuticals Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cardiology Radiopharmaceuticals Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cardiology Radiopharmaceuticals Overall Market Size
2.1 Global Cardiology Radiopharmaceuticals Market Size: 2022 VS 2029
2.2 Global Cardiology Radiopharmaceuticals Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cardiology Radiopharmaceuticals Players in Global Market
3.2 Top Global Cardiology Radiopharmaceuticals Companies Ranked by Revenue
3.3 Global Cardiology Radiopharmaceuticals Revenue by Companies
3.4 Top 3 and Top 5 Cardiology Radiopharmaceuticals Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cardiology Radiopharmaceuticals Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cardiology Radiopharmaceuticals Players in Global Market
3.6.1 List of Global Tier 1 Cardiology Radiopharmaceuticals Companies
3.6.2 List of Global Tier 2 and Tier 3 Cardiology Radiopharmaceuticals Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Cardiology Radiopharmaceuticals Market Size Markets, 2022 & 2029
4.1.2 Technetium-99
4.1.3 Fluorine-18
4.1.4 Gallium-67
4.1.5 Others
4.2 By Type – Global Cardiology Radiopharmaceuticals Revenue & Forecasts
4.2.1 By Type – Global Cardiology Radiopharmaceuticals Revenue, 2018-2023
4.2.2 By Type – Global Cardiology Radiopharmaceuticals Revenue, 2024-2029
4.2.3 By Type – Global Cardiology Radiopharmaceuticals Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cardiology Radiopharmaceuticals Market Size, 2022 & 2029
5.1.2 Therapeutic Use
5.1.3 Diagnostic Use
5.2 By Application – Global Cardiology Radiopharmaceuticals Revenue & Forecasts
5.2.1 By Application – Global Cardiology Radiopharmaceuticals Revenue, 2018-2023
5.2.2 By Application – Global Cardiology Radiopharmaceuticals Revenue, 2024-2029
5.2.3 By Application – Global Cardiology Radiopharmaceuticals Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Cardiology Radiopharmaceuticals Market Size, 2022 & 2029
6.2 By Region – Global Cardiology Radiopharmaceuticals Revenue & Forecasts
6.2.1 By Region – Global Cardiology Radiopharmaceuticals Revenue, 2018-2023
6.2.2 By Region – Global Cardiology Radiopharmaceuticals Revenue, 2024-2029
6.2.3 By Region – Global Cardiology Radiopharmaceuticals Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Cardiology Radiopharmaceuticals Revenue, 2018-2029
6.3.2 US Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.3.3 Canada Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.3.4 Mexico Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Cardiology Radiopharmaceuticals Revenue, 2018-2029
6.4.2 Germany Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4.3 France Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4.4 U.K. Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4.5 Italy Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4.6 Russia Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4.7 Nordic Countries Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.4.8 Benelux Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Cardiology Radiopharmaceuticals Revenue, 2018-2029
6.5.2 China Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.5.3 Japan Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.5.4 South Korea Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.5.5 Southeast Asia Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.5.6 India Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Cardiology Radiopharmaceuticals Revenue, 2018-2029
6.6.2 Brazil Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.6.3 Argentina Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Cardiology Radiopharmaceuticals Revenue, 2018-2029
6.7.2 Turkey Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.7.3 Israel Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.7.4 Saudi Arabia Cardiology Radiopharmaceuticals Market Size, 2018-2029
6.7.5 UAE Cardiology Radiopharmaceuticals Market Size, 2018-2029
7 Cardiology Radiopharmaceuticals Companies Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare Cardiology Radiopharmaceuticals Major Product Offerings
7.1.4 GE Healthcare Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.1.5 GE Healthcare Key News & Latest Developments
7.2 Cardinal Health
7.2.1 Cardinal Health Company Summary
7.2.2 Cardinal Health Business Overview
7.2.3 Cardinal Health Cardiology Radiopharmaceuticals Major Product Offerings
7.2.4 Cardinal Health Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.2.5 Cardinal Health Key News & Latest Developments
7.3 Curium Pharma
7.3.1 Curium Pharma Company Summary
7.3.2 Curium Pharma Business Overview
7.3.3 Curium Pharma Cardiology Radiopharmaceuticals Major Product Offerings
7.3.4 Curium Pharma Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.3.5 Curium Pharma Key News & Latest Developments
7.4 Lantheus Medical Imaging, Inc.
7.4.1 Lantheus Medical Imaging, Inc. Company Summary
7.4.2 Lantheus Medical Imaging, Inc. Business Overview
7.4.3 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Major Product Offerings
7.4.4 Lantheus Medical Imaging, Inc. Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.4.5 Lantheus Medical Imaging, Inc. Key News & Latest Developments
7.5 Eczacıbaşı Monrol Nuclear Products
7.5.1 Eczacıbaşı Monrol Nuclear Products Company Summary
7.5.2 Eczacıbaşı Monrol Nuclear Products Business Overview
7.5.3 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Major Product Offerings
7.5.4 Eczacıbaşı Monrol Nuclear Products Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.5.5 Eczacıbaşı Monrol Nuclear Products Key News & Latest Developments
7.6 Novartis International AG
7.6.1 Novartis International AG Company Summary
7.6.2 Novartis International AG Business Overview
7.6.3 Novartis International AG Cardiology Radiopharmaceuticals Major Product Offerings
7.6.4 Novartis International AG Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.6.5 Novartis International AG Key News & Latest Developments
7.7 Siemens
7.7.1 Siemens Company Summary
7.7.2 Siemens Business Overview
7.7.3 Siemens Cardiology Radiopharmaceuticals Major Product Offerings
7.7.4 Siemens Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.7.5 Siemens Key News & Latest Developments
7.8 China Isotope & Radiation
7.8.1 China Isotope & Radiation Company Summary
7.8.2 China Isotope & Radiation Business Overview
7.8.3 China Isotope & Radiation Cardiology Radiopharmaceuticals Major Product Offerings
7.8.4 China Isotope & Radiation Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.8.5 China Isotope & Radiation Key News & Latest Developments
7.9 Yantai Dongcheng Pharmaceutical
7.9.1 Yantai Dongcheng Pharmaceutical Company Summary
7.9.2 Yantai Dongcheng Pharmaceutical Business Overview
7.9.3 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Major Product Offerings
7.9.4 Yantai Dongcheng Pharmaceutical Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.9.5 Yantai Dongcheng Pharmaceutical Key News & Latest Developments
7.10 Jubilant Life Sciences
7.10.1 Jubilant Life Sciences Company Summary
7.10.2 Jubilant Life Sciences Business Overview
7.10.3 Jubilant Life Sciences Cardiology Radiopharmaceuticals Major Product Offerings
7.10.4 Jubilant Life Sciences Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.10.5 Jubilant Life Sciences Key News & Latest Developments
7.11 Bracco
7.11.1 Bracco Company Summary
7.11.2 Bracco Business Overview
7.11.3 Bracco Cardiology Radiopharmaceuticals Major Product Offerings
7.11.4 Bracco Cardiology Radiopharmaceuticals Revenue in Global Market (2018-2023)
7.11.5 Bracco Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer